Park National Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.14M Buy
116,886
+1,527
+1% +$123K 0.26% 85
2026
Q1
$10M Buy
115,359
+20,569
+22% +$1.97M 0.3% 83
2025
Q4
$9.11M Sell
94,790
-21,343
-18% -$2.07M 0.28% 82
2025
Q3
$11.1M Sell
116,133
-9,241
-7% -$849K 0.35% 74
2025
Q2
$10.9M Sell
125,374
-1,408
-1% -$119K 0.36% 71
2025
Q1
$11.4M Sell
126,782
-5,791
-4% -$518K 0.42% 66
2024
Q4
$10.6M Sell
132,573
-4
-0% -$346 0.39% 61
2024
Q3
$11.9M Buy
132,577
+56,545
+74% +$4.76M 0.42% 65
2024
Q2
$5.98M Buy
76,032
+72,415
+2,002% +$5.94M 0.22% 83
2024
Q1
$315K Buy
3,617
+216
+6% +$18.4K 0.01% 231
2023
Q4
$280K Sell
3,401
-3,470
-51% -$264K 0.01% 245
2023
Q3
$538K Sell
6,871
-969
-12% -$81.1K 0.02% 201
2023
Q2
$691K Sell
7,840
-850
-10% -$73.2K 0.03% 183
2023
Q1
$701K Sell
8,690
-698
-7% -$56.9K 0.03% 179
2022
Q4
$730K Sell
9,388
-1,155
-11% -$93.6K 0.03% 176
2022
Q3
$852K Buy
10,543
+62
+0.6% +$5.57K 0.04% 158
2022
Q2
$941K Buy
10,481
+28
+0.3% +$2.84K 0.05% 160
2022
Q1
$1.16M Sell
10,453
-1,309
-11% -$138K 0.05% 148
2021
Q4
$1.22M Sell
11,762
-3,260
-22% -$377K 0.05% 146
2021
Q3
$1.88M Sell
15,022
-1,668
-10% -$216K 0.08% 127
2021
Q2
$2.07M Sell
16,690
-3,122
-16% -$392K 0.09% 123
2021
Q1
$2.34M Sell
19,812
-3,671
-16% -$430K 0.1% 114
2020
Q4
$2.75M Sell
23,483
-309
-1% -$34K 0.13% 98
2020
Q3
$2.47M Sell
23,792
-1,759
-7% -$177K 0.13% 98
2020
Q2
$2.34M Sell
25,551
-3,173
-11% -$304K 0.13% 98
2020
Q1
$2.59M Sell
28,724
-450
-2% -$47.9K 0.16% 90
2019
Q4
$3.31M Buy
29,174
+66
+0.2% +$7.24K 0.17% 87
2019
Q3
$3.16M Sell
29,108
-1,671
-5% -$174K 0.17% 92
2019
Q2
$3M Sell
30,779
-3,602
-10% -$329K 0.16% 94
2019
Q1
$3.13M Sell
34,381
-2,895
-8% -$259K 0.18% 92
2018
Q4
$3.39M Sell
37,276
-1,255
-3% -$117K 0.21% 83
2018
Q3
$3.79M Sell
38,531
-403
-1% -$37.3K 0.21% 76
2018
Q2
$3.33M Sell
38,934
-5,554
-12% -$464K 0.19% 79
2018
Q1
$3.57M Sell
44,488
-10,179
-19% -$840K 0.21% 75
2017
Q4
$4.42M Sell
54,667
-16,155
-23% -$1.29M 0.25% 73
2017
Q3
$5.51M Sell
70,822
-14,640
-17% -$1.22M 0.32% 61
2017
Q2
$7.58M Sell
85,462
-9,039
-10% -$762K 0.45% 52
2017
Q1
$7.61M Sell
94,501
-52,189
-36% -$4.08M 0.46% 51
2016
Q4
$10.4M Sell
146,690
-27,537
-16% -$2.16M 0.64% 45
2016
Q3
$15.1M Sell
174,227
-14,348
-8% -$1.25M 0.96% 33
2016
Q2
$16.4M Sell
188,575
-14,726
-7% -$1.19M 1.05% 29
2016
Q1
$15.2M Sell
203,301
-17,588
-8% -$1.32M 1.01% 31
2015
Q4
$17M Sell
220,889
-5,177
-2% -$390K 1.15% 28
2015
Q3
$15.1M Sell
226,066
-5,836
-3% -$430K 1.09% 29
2015
Q2
$17.2M Sell
231,902
-5,644
-2% -$431K 1.18% 29
2015
Q1
$18.5M Sell
237,546
-2,874
-1% -$218K 1.26% 28
2014
Q4
$17.4M Sell
240,420
-1,950
-0.8% -$135K 1.15% 29
2014
Q3
$15M Sell
242,370
-1,266
-0.5% -$80.5K 1.09% 29
2014
Q2
$15.5M Sell
243,636
-5,060
-2% -$307K 1.07% 28
2014
Q1
$15.3M Sell
248,696
-16,691
-6% -$972K 1.09% 26
2013
Q4
$15.2M Sell
265,387
-4,112
-2% -$233K 1.08% 24
2013
Q3
$14.4M Buy
269,499
+4,796
+2% +$258K 1.1% 23
2013
Q2
$13.6M Buy
+264,703
New +$13.1M 1.1% 23

Other funds holding MDT

Park National Corp's MDT Position: Q2 2026 in Review

Park National Corp increased its Medtronic (MDT) stake by 1.3% in Q2 2026, buying an estimated $123K and bringing the position to 116,886 shares worth $9.14M. The position accounts for 0.26% of the portfolio, ranked #85.

Park National Corp first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.5M in Q1 2015. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Park National Corp held 116,886 shares of Medtronic worth $9.14M as of Q2 2026.
  • Park National Corp bought 1,527 Medtronic shares in Q2 2026, an estimated $123K.
  • Medtronic made up 0.26% of Park National Corp's portfolio in Q2 2026, its #85 holding.
  • Park National Corp first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Park National Corp's Medtronic position peaked at $18.5M in Q1 2015.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.